Pay in 4 interest-free payments of $15.00 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Cilengitide inhibits the attachment of human umbilical vein endothelial cells to Vitronectin with an IC50 of 2 μM
63(2):601-612
InChi: InChI=1S/C19H22N8O6S2
PSI-7977 13CD3
degrades clinically relevant androgen receptor point mutants and unlike enzalutamide
RGFP966(EE) - CAS# 1396841-57-8 805 dihydrochloride Cilengitide inhibits the attachment ofRGFP966 is a selective HDAC3 inhibitor . S ystemic treatment with RGFP966 facilitates extinction in mice in a manner resistant to reinstatement. A single treatment of RGFP966 enhances extinction of a previously established cocaine conditioned place preference, while simultaneously enhancing long term object location memory within subjects. During extinction consolidation, HDAC3 inhibition promotes a distinct pattern of histone acetylation linked to
US$ 10.00
US$ 15.00
US$ 10.00
US$ 50.00
US$ 10.00
US$ 80.00
US$ 10.00
US$ 55.00
US$ 12.00